Picture of INVO Fertility logo

IVF — INVO Fertility News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Invo Bioscience Inc Expected To Post A Loss Of 20 Cents A Share: Earnings Preview

* INVO Bioscience Inc  INVO.OQ   INVO.O  is expected to report
results on November 15.
* The Lakewood Ranch, Florida-based company is expected to
report revenue of $325.5 thousand, according to the mean
estimate from 2 analysts, based on Refinitiv data.  
​* Refinitiv's mean analyst estimate for INVO Bioscience Inc is
for a loss of 20 cents per share. 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for INVO Bioscience
Inc is $5.63​, about 41.3% above​ its last closing price
of $3.30. ​​​
This summary was machine generated November 12 at 23:32 GMT. 
All figures in US dollars  unless otherwise stated

Recent news on INVO Fertility

See all news